Alaunos Therapeutics | ZIOP - Cash And Equivalent


Alaunos Therapeutics reported $354K in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 354K 1.03M Mar/2026
Amgen USD 12.04B 2.91B Mar/2026
AstraZeneca USD 7.56B 1.85B Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Biogen USD 3.38B 374.2M Mar/2026
Bioline Rx USD 7.91M 725K Sep/2025
Bristol-Myers Squibb USD 9.57B 635M Mar/2026
Celltrion KRW 49.87B 20.22B Dec/2025
Corcept Therapeutics USD 108.74M 11.76M Mar/2026
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Curis USD 10.14M 10.14M Jun/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Gilead Sciences USD 7.56B 234M Dec/2025
GlaxoSmithKline GBP 3.44B 292M Mar/2026
Incyte USD 4.02B 435.22M Mar/2026
Intrexon USD 9.34M 1.77M Jun/2024
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Karyopharm Therapeutics USD 60.54M 22.87M Dec/2025
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Merck USD 5.33B 9.24B Mar/2026
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Novartis USD 6.88B 4.56B Mar/2026
Organigram Holdings CAD 7.58M 20.62M Dec/2025
Pfizer USD 1.7B 561M Mar/2026
Pharma Mar EUR 48.86M 31.05M Mar/2026
PTC Therapeutics USD 833.99M 150.66M Mar/2026
Qiagen NV USD 839M 516.58M Dec/2025
Regeneron Pharmaceuticals USD 2.96B 15.9B Mar/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sartorius EUR 573.8M 32.4M Mar/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
TG Therapeutics USD 442.21M 242.7M Mar/2026
Tilray USD 264.83M 43.16M Jun/2025
Verastem USD 204.99M 67.28M Dec/2025
Zealand Pharma A/S 4.58B 1.4B Dec/2025
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026